C146H190N16O10 — CID 159030378
(2R)-2-[(3S)-3-[[4-[3-benzyl-1-(carboxymethyl)pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[1-ethyl-5-(1-phenylcyclopropyl)pyrazol-3-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S)-3-phenyl-4-[[4-[3-(1-phenylcyclopropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-[3-(1-phenylpropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid (PubChem CID 159030378) has the molecular formula C146H190N16O10 and a molecular weight of 2329.23 g/mol. Its IUPAC name is (2R)-2-[(3S)-3-[[4-[3-benzyl-1-(carboxymethyl)pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[1-ethyl-5-(1-phenylcyclopropyl)pyrazol-3-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S)-3-phenyl-4-[[4-[3-(1-phenylcyclopropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-[3-(1-phenylpropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid.
| Compound Name | (2R)-2-[(3S)-3-[[4-[3-benzyl-1-(carboxymethyl)pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[1-ethyl-5-(1-phenylcyclopropyl)pyrazol-3-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S)-3-phenyl-4-[[4-[3-(1-phenylcyclopropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-[3-(1-phenylpropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid |
|---|---|
| PubChem CID | 159030378 |
| Molecular Formula | C146H190N16O10 |
| Molecular Weight | 2329.23 g/mol |
| Exact Mass | 2327.49 |
| IUPAC Name | (2R)-2-[(3S)-3-[[4-[3-benzyl-1-(carboxymethyl)pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[1-ethyl-5-(1-phenylcyclopropyl)pyrazol-3-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S)-3-phenyl-4-[[4-[3-(1-phenylcyclopropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-[3-(1-phenylpropyl)-1H-pyrazol-5-yl]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid |
| SMILES | CCC(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1.CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1C1(c2ccccc2)CC1.O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)CC2c2ccccc2)CC1.O=C(O)[C@@H](C1CCCCC1)N1CC(CN2CCC(c3cc(C4(c5ccccc5)CC4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 |
| InChI | InChI=1S/C38H50N4O2.C36H46N4O4.C36H46N4O2.C36H48N4O2/c1-2-42-35(38(20-21-38)32-16-10-5-11-17-32)24-34(39-42)29-18-22-40(23-19-29)25-31-26-41(27-33(31)28-12-6-3-7-13-28)36(37(43)44)30-14-8-4-9-15-30;41-34(42)25-40-33(21-31(37-40)20-26-10-4-1-5-11-26)28-16-18-38(19-17-28)22-30-23-39(24-32(30)27-12-6-2-7-13-27)35(36(43)44)29-14-8-3-9-15-29;41-35(42)34(28-12-6-2-7-13-28)40-24-29(31(25-40)26-10-4-1-5-11-26)23-39-20-16-27(17-21-39)32-22-33(38-37-32)36(18-19-36)30-14-8-3-9-15-30;1-2-31(26-12-6-3-7-13-26)34-22-33(37-38-34)28-18-20-39(21-19-28)23-30-24-40(25-32(30)27-14-8-4-9-15-27)35(36(41)42)29-16-10-5-11-17-29/h3,5-7,10-13,16-17,24,29-31,33,36H,2,4,8-9,14-15,18-23,25-27H2,1H3,(H,43,44);1-2,4-7,10-13,21,28-30,32,35H,3,8-9,14-20,22-25H2,(H,41,42)(H,43,44);1,3-5,8-11,14-15,22,27-29,31,34H,2,6-7,12-13,16-21,23-25H2,(H,37,38)(H,41,42);3-4,6-9,12-15,22,28-32,35H,2,5,10-11,16-21,23-25H2,1H3,(H,37,38)(H,41,42)/t31-,33+,36+;30-,32?,35+;29?,31-,34-;30-,31?,32+,35+/m0010/s1 |
| InChIKey | JUUSFHVSJWIRNE-OEMYDEBXSA-N |
| XLogP | 25.70 |
| TPSA | 305.42 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2329.23 |
| LogP ≤ 5 | 25.70 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 19 |